rs121913047
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000122.2(ERCC3):c.1273C>T(p.Arg425*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000122.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251402Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135894
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461880Hom.: 0 Cov.: 33 AF XY: 0.00000550 AC XY: 4AN XY: 727240
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74312
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Reported in trans with a second ERCC3 variant in two sisters with features of xeroderma pigmentosa (Oh et al., 2006); Published functions studies demonstrate a damaging effect resulting in defective DNA repair activity (Oh et al., 2006); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 20947453, 26884178, 28588253, 29376097, 27004399, 19199647, 16947863, 26689913, 29625052) -
This sequence change creates a premature translational stop signal (p.Arg425*) in the ERCC3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC3 are known to be pathogenic (PMID: 16947863). This variant is present in population databases (rs121913047, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with ERCC3-related conditions (PMID: 16947863, 26884178). ClinVar contains an entry for this variant (Variation ID: 16585). For these reasons, this variant has been classified as Pathogenic. -
Xeroderma pigmentosum group B;C4225344:Trichothiodystrophy 2, photosensitive Pathogenic:1
- -
Inborn genetic diseases Pathogenic:1
The c.1273C>T (p.R425*) alteration, located in exon 8 (coding exon 8) of the ERCC3 gene, consists of a C to T substitution at nucleotide position 1273. This changes the amino acid from a arginine (R) to a stop codon at amino acid position 425. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the T allele has an overall frequency of <0.01% (2/251402) total alleles studied. The highest observed frequency was <0.01% (2/113682) of European (non-Finnish) alleles. This alteration has been reported along with a second ERCC3 alteration in patients with features of ERCC3-related spectrum disorders (Garcia-Moreno, 2018; Oh, 2006). Functional studies show that this alteration leads to greatly reduced activity compared to wild type (Oh, 2006). Based on the available evidence, this alteration is classified as pathogenic. -
Xeroderma pigmentosum group B Pathogenic:1
- -
Trichothiodystrophy 2, photosensitive Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at